| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2026 | 21 May 2026 |
| Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the fourth Quarter as well as Financial Year ended on 31st March 2026. | ||
| Board Meeting | 13 Feb 2026 | 3 Feb 2026 |
| Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve 1. the Un-Audited Financial Results of the Company for the Quarter and Nine Month ended on 31st December, 2025 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair. Outcome of Board Meeting held on Friday 13th February, 2026 (As Per BSE Announcement Dated on 13.02.2026) | ||
| Board Meeting | 13 Nov 2025 | 7 Nov 2025 |
| Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve To consider and approve the Unaudited Financial results of the Company for the Quarter and half year ended on 30th September 2025. To review, consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2025 along with Limited Review Report (As Per BSE Announcement Dated on: 13/11/2025) | ||
| Board Meeting | 12 Aug 2025 | 4 Aug 2025 |
| Quarterly Results Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve 1.To consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June, 2025 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair. (As Per BSE Announcement Dated on :04.08.2025) Change in Registered office within City Outcome of Board Meeting held on Tuesday 12th August, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 Un-Audited Financial Results for the quarter ended 30th June 2025 (As per BSE Announcement Dated on 12/08/2025) | ||
| Board Meeting | 4 Aug 2025 | 4 Aug 2025 |
| Outcome of Board Meeting held on Monday 04th August, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
